Ainos (NASDAQ:AIMD) Posts Quarterly Earnings Results

Ainos (NASDAQ:AIMD) announced its earnings results on Monday. The company reported ($0.21) earnings per share for the quarter, Zacks reports. The business had revenue of $0.11 million during the quarter.

Ainos Price Performance

Shares of AIMD opened at $0.55 on Tuesday. The firm has a market capitalization of $8.49 million, a price-to-earnings ratio of -0.33 and a beta of 2.14. The company has a debt-to-equity ratio of 0.50, a quick ratio of 1.33 and a current ratio of 1.37. Ainos has a one year low of $0.40 and a one year high of $1.46. The stock’s fifty day moving average is $0.52 and its 200-day moving average is $0.54.

About Ainos

Ainos, Inc, a healthcare company, engages in developing medical technologies for point-of-care testing and safe and novel medical treatment for disease indications. The company offers COVID-19 antigen rapid test kit and Ainos’ cloud-based test management App, a cloud-based test management platform comprising an antigen rapid test kit, a personal application, and an enterprise app; COVID-19 nucleic acid test; volatile organic compounds point-of-care testing; Very Low-Dose Oral Interferon Alpha, a low-dose oral interferon alpha formulation based IFN-a’s broad treatment applications; and Synthetic RNA developing a SRNA technology platform in Taiwan.